RxDoctor Payments Data

Dino Romero

General Practice · Parrish, FLNPI 1730766114

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Gilead at 30.6% of the total.

$1,567in general payments, 2019–2025

Across 46 payments — averaging $34.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$480
  • Novo Nordisk$201
  • AstraZeneca$156
  • Mallinckrodt Hospital Products Inc.$146
  • Davol Inc.$117
  • AbbVie$56
  • plus $412 from 16 others

What the payments were for

  • Food & beverage$1,567100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,567 in reported general payments places this provider in the 85th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida →

Other general practice in Parrish

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →